Major advances in cardiovascular medicine have been driven by innovations in basic research in biological and technical sciences. Despite the clear evidence regarding the treatments that have been demonstrated to be useful to improve patients' outcomes, their transferability to everyday clinical practice seems to be at least suboptimal. The European Society of Cardiology (ESC), therefore, planned to support a program, denominated EuroHeart, for continuous data collection of standardized and/or harmonized variables in common cardiovascular diseases, such as ACS, HF and A Fib. EuroHeart is an observational, prospective, multicentre initiative with continuous data collection in consecutive patients with ACS, HF and A Fib to support continuous quality of care improvement through the evaluation of quality indicators (QIs) defined by the ESC. All patients included in the EuroHeart initiative, will enter a 12 month longitudinal follow-up with the collection of clinical events and clinical status data.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Adherence to ESC Quality indicators (STEMI patients reperfused)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (STEMI patients reperfused <90 min)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (coronary angiography in NSTEMI patients within 24 hours)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (radial access)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (time to reperfusion in STEMI patients)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (pre-discharge LVEF evaluation in STEMI and NSTEMI patients)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (in hospital LDL-c evaluation in STEMI and NSTEMI patients)
Timeframe: From enrollment to 12 months follow-up
Furio Colivicchi, MD
Adherence to ESC Quality indicators (DAPT prescription at discharge in STEMI and NSTEMI patients)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (LLA prescription at discharge in STEMI and NSTEMI patients)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (ACEi/ARB/ARNI prescription at discharge in patients with LVEF ≤40%)
Timeframe: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (Beta blockers prescription at discharge in patients with LVEF ≤40%)
Timeframe: From enrollment to 12 months follow-up